Mark Altmeyer serves as Executive at Axovant Sciences Ltd., where they oversee executive responsibilities. Since joining the company, Mark Altmeyer has executed 3 insider transactions totaling $72.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 19, 2024 involved receiving (via award) 41,250 shares valued at $0.
Mark Altmeyer currently holds 41,250 shares of Axovant Sciences Ltd. (AXON), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Altmeyer has been a net buyer of AXON stock. They have purchased $72.5K and sold $0 worth of shares.
Mark Altmeyer's most recent insider trade was on Mar 19, 2024, when they sold 41,250 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $13.38 |
| Discretionary |
| Mar 10, 2016 | AXON | $25.6K | Purchase | 2,300 | $11.14 | Discretionary |